Order Article Reprints

Avgerinos KI, Mullins RJ, Vreones M, Mustapic M, Chen Q, Melvin D, Kapogiannis D, Egan JM. Empagliflozin Induced Ketosis, Upregulated IGF-1/Insulin Receptors and the Canonical Insulin Signaling Pathway in Neurons, and Decreased the Excitatory Neurotransmitter Glutamate in the Brain of Non-Diabetics. Cells. 2022; 11(21):3372. https://doi.org/10.3390/cells11213372

Avgerinos, Konstantinos I., Roger J. Mullins, Michael Vreones, Maja Mustapic, Qinghua Chen, Denise Melvin, Dimitrios Kapogiannis, and Josephine M. Egan. 2022. "Empagliflozin Induced Ketosis, Upregulated IGF-1/Insulin Receptors and the Canonical Insulin Signaling Pathway in Neurons, and Decreased the Excitatory Neurotransmitter Glutamate in the Brain of Non-Diabetics" Cells 11, no. 21: 3372. https://doi.org/10.3390/cells11213372

Avgerinos, K. I., Mullins, R. J., Vreones, M., Mustapic, M., Chen, Q., Melvin, D., Kapogiannis, D., & Egan, J. M. (2022). Empagliflozin Induced Ketosis, Upregulated IGF-1/Insulin Receptors and the Canonical Insulin Signaling Pathway in Neurons, and Decreased the Excitatory Neurotransmitter Glutamate in the Brain of Non-Diabetics. Cells, 11(21), 3372. https://doi.org/10.3390/cells11213372